Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study. - Ohtani M; Yokoo T; Miyazaki T; Yasuda H; Nishikawa E; Tomida M; Tsukada M; Sato E; Hirayama S; Murakami H; Yoshizawa S; Matsumoto T; et al. (Journal of pharmaceutical health care and sciences, 2025)